drugset / Trial / NCT00776555
Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution
RandomizedCrossoverSingle-blindOther
Summary
The purpose of this study is to compare subjective drug liking using the Drug Rating Questionnaire, subject version (DRQ-S), question 2 and pharmacokinetics of Vyvanse™ and ADDERALL XR® when administered as an oral solution. Hypothesis: DRQ-S, question 2 will show no difference between the two drugs
Timeline
- Start
- 2008-11-21
- Primary completion
- 2009-03-31
- Completion
- 2009-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lisdexamfetamine | Other / unclassified | 20 mg | Oral |
| Subject | Lisdexamfetamine | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.